Tina Reed

Tina Reed is a health care editor for Axios. She is the author of the daily Axios Vitals newsletter, covering health care politics, policy and business. Reed has been with Axios since 2017 and previously worked at Politico as a reporter covering health care policy. Her reporting focuses on pharmaceutical companies, drug pricing, and government regulation in the industry. She has a Bachelor's degree in journalism from the University of Maryland.

Biography:  https://www.axios.com/authors/treed

75%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

88%

Examples:

  • The author occasionally presents information in a way that could be considered misleading or deceptive.

Conflicts of Interest

88%

Examples:

  • The author occasionally mentions potential conflicts of interest but does not delve deeply into them.

Contradictions

92%

Examples:

  • Contradictions are consistently identified and reported in the articles analyzed.

Deceptions

46%

Examples:

  • The author occasionally presents information in a way that could be considered misleading or deceptive.

Recent Articles

FDA Approves Eli Lilly's Donanemab: A New Hope for Early Alzheimer's Disease Patients

FDA Approves Eli Lilly's Donanemab: A New Hope for Early Alzheimer's Disease Patients

Broke On: Tuesday, 02 July 2024 The FDA approves Eli Lilly's donanemab, the second drug for treating early Alzheimer's symptoms. This first-of-its-kind treatment targets amyloid protein deposits in the brain and slows down disease progression, allowing patients to live more independently. Despite reported side effects, benefits outweigh risks with a 39% reduced risk of clinical stage progression. Donanemab costs $12,522 for six months or about $32,000 per year.
New Study Reveals Which Antidepressants Are Most Likely to Cause Weight Gain

New Study Reveals Which Antidepressants Are Most Likely to Cause Weight Gain

Broke On: Monday, 01 July 2024 A recent study published in the Annals of Internal Medicine found that escitalopram and paroxetine users gained roughly 1 pound more than sertraline users after six months, with a higher likelihood of gaining at least 5% of their baseline weight. Bupropion saw the least amount of weight gain among first-line antidepressants. The study offers more detailed information on antidepressant impact on weight gain and aims to help providers and patients make informed decisions.
CDC and Wastewater Data Show COVID-19 Cases on the Rise: Midwest, Northeast, and South See Increase in Viral Loads

CDC and Wastewater Data Show COVID-19 Cases on the Rise: Midwest, Northeast, and South See Increase in Viral Loads

Broke On: Thursday, 27 June 2024 CDC data and wastewater surveillance indicate a rise in COVID-19 cases, driven by new variants KP.3 and KP.2, with 39 states experiencing growth or likely growth as of the latest data. Experts attribute this increase to indoor gatherings during summer heat and the July 4 travel period. While this summer wave is expected to remain mild, individuals should remain vigilant, particularly those who are medially vulnerable. Houston wastewater viral load has increased by 273%, prompting local health officials to encourage precautions.
Bird Flu Spreads in US: Over 100 Dairy Cattle Herds Affected, Milk Production Decreases in Texas and Kansas

Bird Flu Spreads in US: Over 100 Dairy Cattle Herds Affected, Milk Production Decreases in Texas and Kansas

Broke On: Tuesday, 18 June 2024 Bird flu, a highly contagious virus affecting birds and impacting dairy cattle herds across the US since March 2024, has led to decreased milk production in Texas and Kansas. The H5N1 strain has been detected in over 80 million chickens, wild birds, and mammals globally. Experts warn of potential undetected cases among cows and humans due to limited testing availability. Farmers are advised to implement biosecurity measures, vaccinations, and testing to prevent further spread.
Avian Flu Spreads Among Dairy Cattle: Concerns Over Human Transmission and Data Gaps

Avian Flu Spreads Among Dairy Cattle: Concerns Over Human Transmission and Data Gaps

Broke On: Monday, 17 June 2024 Growing concerns over the spread of avian flu among dairy cattle in the US, with at least 94 herds testing positive across 12 states. Experts worry about increased human transmission risk and the potential for virus mutation. Michigan is a hotspot despite no known outbreaks, as wastewater shows high levels of H5 influenza A virus. Lack of data on avian flu spread in dairy herds leaves federal government without sufficient information to contain the issue.
FDA Approves Moderna's RSV Vaccine for Older Adults: A New Weapon Against Respiratory Disease

FDA Approves Moderna's RSV Vaccine for Older Adults: A New Weapon Against Respiratory Disease

Broke On: Friday, 31 May 2024 Moderna's RSV vaccine, mResvia, has received FDA approval for older adults, marking the second product from the company to be approved after its Covid-19 vaccine. The vaccine is designed to protect against lower respiratory tract disease caused by RSV infection in adults aged 60 and above. With an 83.7% efficacy rate, mResvia will join GlaxoSmithKline's Arexvy and Pfizer's Abrysvo as crucial tools for protecting older adults during the upcoming RSV season.
New USPSTF Guidelines: Mammograms Every Other Year for Women Aged 40 and Above

New USPSTF Guidelines: Mammograms Every Other Year for Women Aged 40 and Above

Broke On: Tuesday, 30 April 2024 The US Preventive Services Task Force now recommends that women get mammograms every other year starting at age 40, following rising breast cancer rates among younger women. The new guidelines bring the USPSTF closer in line with other health organizations and require insurers to cover mammograms for women in their 40s, but concerns remain over potential harms and costs for supplemental screening.
Walgreens Expands Specialty Pharmacy Business with Focus on Gene and Cell Therapies: New Facility, 1,500 Specialty-Trained Pharmacists, and $24 Billion Market

Walgreens Expands Specialty Pharmacy Business with Focus on Gene and Cell Therapies: New Facility, 1,500 Specialty-Trained Pharmacists, and $24 Billion Market

Broke On: Thursday, 25 April 2024 Walgreens launches Walgreens Specialty Pharmacy, a $24 billion business focusing on gene and cell therapies, integrating new services with existing assets. The expansion includes an 18,000-sqft facility in Pittsburgh to manage complex supply chains for high-cost treatments like cancer and HIV. With over 1,500 specialty-trained pharmacists and 5,000 patient advocacy team members, Walgreens Specialty Pharmacy aims to improve financial performance through expanded offerings in the specialty pharmacy market.
FTC's Decision to Ban Most Noncompete Agreements: Implications for 30 Million American Workers and Businesses

FTC's Decision to Ban Most Noncompete Agreements: Implications for 30 Million American Workers and Businesses

Broke On: Tuesday, 23 April 2024 The FTC's decision to ban most noncompete agreements, affecting around 30 million workers, could lead to increased wages of nearly $300 billion annually by promoting job mobility. The policy change has sparked controversy, with supporters arguing it stifles worker freedom and critics claiming it's necessary for businesses. The FTC received over 26,000 public comments on the issue and plans to implement the ban later this year despite ongoing legal challenges.
Melatonin Gummies Cause 11,000 Emergency Visits Among Infants and Young Children: Study by Centers for Disease Control and Prevention (CDC)

Melatonin Gummies Cause 11,000 Emergency Visits Among Infants and Young Children: Study by Centers for Disease Control and Prevention (CDC)

Broke On: Thursday, 07 March 2019 Melatonin, a sleep hormone, linked to thousands of emergency visits by children. CDC reports 11,000 cases between 2019 and 2022 involving flavored products like gummies.